<DOC>
	<DOCNO>NCT00094640</DOCNO>
	<brief_summary>The goal study : Determine blood level intramuscular ( IM ) olanzapine depot patient different point time injection , compare level amount olanzapine blood patient treat oral administration Zyprexa ( olanzapine ) tablets intramuscular administration Zyprexa IntraMuscular ( olanzapine injection ) .</brief_summary>
	<brief_title>Pharmacokinetic Characterization Intramuscular Olanzapine Depot</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Patients must schizophrenia schizoaffective disorder . Each patient must level understanding sufficient complete test examination require protocol , provide informed consent . Patient must participate clinical trial another investigational drug , include olanzapine , within 1 month ( 30 day ) prior study entry . Female patient must pregnant breastfeeding . Patients must experience acute , serious , unstable medical condition schizophrenia schizoaffective disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>